Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Classement en actions #6297
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Prix de l'action
$115.48
Capitalisation boursière
$2.12B
Changement (1 jour)
0.72%
Changement (1 an)
29.38%
Pays
KR
Échange Voronoi, Inc. (310210)

Catégorie

Historique du prix de l'action pour Voronoi, Inc. (310210)
Prix de clôture le plus élevé : $117.55 le 2026-08-01

Prix de clôture le plus bas : $21.91 le 2022-06-01
Historique du prix de l'action de Voronoi, Inc. de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.57%
2025 181.09%
2024 62.84%
2023 71.45%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH